title: Nasal extranodal peripheral NK/T-cell lymphoma treated by the protocol NK/T-cell high-dose-methotrexate L-asparaginase dexamethasone.
authors: M A
authors: MA
authors: Bekadja
authors: H
authors: H
authors: Benredouane
authors: J
authors: J
authors: Audouin
authors: D
authors: D
authors: Mansouri
authors: H
authors: H
authors: Mehadji
authors: M
authors: M
authors: Brahimi
authors: A
authors: A
authors: Arabi
authors: S
authors: S
authors: Osmani
authors: B
authors: B
authors: Entasoltane
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D054391:Lymphoma, Extranodal NK-T-Cell / Q000188:drug therapy*; D008297:Male; D008727:Methotrexate / Q000627:therapeutic use*; D009669:Nose Neoplasms / Q000188:drug therapy*
chemical_list: D003907:Dexamethasone; D001215:Asparaginase; D008727:Methotrexate